Cetera Investment Advisers
IMRX icon

Cetera Investment Advisers’s Immuneering IMRX Stock Holding History

Cetera Investment Advisers’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Buy
22,446
+9,797
+77% +$49.6K ﹤0.01% 4646
2026
Q1 		$66.7K Buy
+12,649
New +$64.8K ﹤0.01% 4543

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Cetera Investment Advisers's IMRX Position: Q2 2026 in Review

Cetera Investment Advisers increased its Immuneering (IMRX) stake by 77% in Q2 2026, buying an estimated $49.6K and bringing the position to 22,446 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #4646.

Cetera Investment Advisers first reported a position in IMRX in Q1 2026 and has held it in 2 quarters since. 111 funds tracked by Wall St. Rank hold IMRX as of Q2 2026.

  • Cetera Investment Advisers held 22,446 shares of Immuneering worth $112K as of Q2 2026.
  • Cetera Investment Advisers bought 9,797 Immuneering shares in Q2 2026, an estimated $49.6K.
  • Immuneering made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4646 holding.
  • Cetera Investment Advisers first reported a position in Immuneering in Q1 2026 and has held it in 2 quarters since.
  • 111 funds tracked by Wall St. Rank held Immuneering as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.